A multicenter, open-label trial to assess the long-term safety and efficacy of lacosamide in subjects with painful diabetic neuropathy.

Trial Profile

A multicenter, open-label trial to assess the long-term safety and efficacy of lacosamide in subjects with painful diabetic neuropathy.

Completed
Phase of Trial: Phase III

Latest Information Update: 25 Nov 2016

At a glance

  • Drugs Lacosamide (Primary)
  • Indications Diabetic neuropathies; Neuropathic pain
  • Focus Adverse reactions; Registrational
  • Sponsors Schwarz BioSciences; Schwarz Pharma AG; UCB
  • Most Recent Events

    • 15 Sep 2009 UCB added as trial sponsor and affiliate as reported by ClinicalTrials.gov.
    • 03 Jan 2008 Status changed from in progress to completed.
    • 30 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top